Search for: "Novartis International AG"
Results 81 - 100
of 120
Sort by Relevance
|
Sort by Date
23 Sep 2010, 9:36 am
Food and Drug Administration ("FDA") approved Fingolimod capsules (Gilenya, Novartis International AG) for reducing the frequency of relapses and delaying the accumulation of disabling symptoms in relapsing forms of Multiple Sclerosis ("MS"). [read post]
19 Aug 2010, 9:02 pm
Depending on the product in question, competition concerns arose in either a few or a larger number of EC member states.The FTC complaint and proposed consent order, In the Matter of Novartis AG, FTC Dkt. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Levitra (Vardenafil) – US: Patent infringement complaint following a Paragraph IV certification: Bayer Schering Pharma AG et al. v. [read post]
22 Jul 2010, 8:35 am
Ian Bryan, IP Counsel, GE Healthcare Vineet Kohli, Senior Patent Attorney, Merck John Beatty, Patent Procedures Management, European Patent Office Dr Roman Maksymiw, Head of Division, German Patent and Trademark Office, DPMA Lawrence Cullen, Deputy Director, IPO Dr Scott Alban, Head of IP, MedImmune Allen Norris, Vice President, Head Group IP, UCB Pharma SA Peter Thomsen, Manager Global IP Litigation and Global Policy, Novartis International AG … [read post]
14 Jul 2010, 6:47 pm
Abbott Laboratories Ltd v Medinol Ltd (PatLit) US: Analysis shows patent use codes have doubled since August 2003 (FDA Law Blog) US: House slips pay-for-delay provision into Appropriations Bill (Patent Docs) US: Novartis challenges USPTO’s interim procedure for requesting PTA recalculations (Patent Docs) US: Seven actions related to Enzo’s patents for detecting DNA stayed pending Supreme Court review (Patent Docs) US: Review and correction of the patent term adjustment… [read post]
6 Jul 2010, 9:59 pm
Click here for further details.The decision of the Court of Appeal for England and Wales in Actavis UK Limited v Novartis AG -- which has the distinction of being the most-commented-upon ruling ever to have been posted on this weblog -- was bound to be the subject of an appeal. [read post]
21 Jun 2010, 8:45 am
About the Authors Philip Grubb is an Intellectual Property Consultant; formerly Intellectual Property Counsel, Novartis International AG; Adjunct professor, Franklin Pierce Law Center, Concord, NH. [read post]
15 Jun 2010, 7:50 pm
International Book Stores & Ors. [read post]
22 Apr 2010, 3:51 am
(Patent Docs) Bystolic (Nebivolol) – Austrian Supreme Court on limitation of patent claims: Case no 17 Ob 24/09t (EPLAW) Denegard / Milbemite / Ocupress - US: District Court W D Tennessee: False marking complaint: Baker v Novartis Pharmaceuticals et al (Patent Docs) Felbatol (Felbamate) – US: CAFC affirms District Court decision enforcing settlement agreement regarding the transfer of patent ownership: MedPointe Healthcare, Inc v Kozachuk (not precedential) (Patent Docs) Husar… [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Aplenzin (Bupropion) - US: District Court Delaware: Patent infringement complaint filed following a Paragraph IV Certification: Biovail Laboratories International SRL v. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
12 Feb 2010, 6:55 am
In the latest example, Bayer AG failed this week to persuade the Delhi High Court to direct India’s chief drug regulator to not give marketing approval to a competitor’s copy of its cancer medicine Nexavar. [read post]
20 Aug 2009, 1:06 pm
For example, in 2004, Teva filed and won a lawsuit against Novartis International AG. [read post]
27 Jul 2009, 7:18 am
: Whirlpool Corporation v Kenwood Ltd (IPKat) EWHC (Pat): EP 258 valid in Netherlands but not UK: Novartis AG and Cibavision AG v Johnson & Johnson Medical Ltd & Ors (IPKat) EWHC (QB): When lawfully seized items can’t be retained under s 22 Police and Criminal Evidence Act 1984 (1709 Copyright Blog) United States US General Obama IP vacancies (IP Frontline) Kappos confirmation hearing set for 29 July (IP Watchdog) (IAM) (Peter Zura's 271… [read post]
13 Jul 2009, 6:45 am
(Afro-IP) Spain Trade mark cancellation and damages: a matter of (bad) faith (Class 46) United Kingdom EWHC (Pat): No ruling on hypothetical issue: MMI Research Ltd v Cellxion Ltd (IPKat) EWHC (Pat): EP 258 valid in Netherlands but not UK: Novartis AG and Cibavision AG v Johnson & Johnson Medical Ltd & Ors (PatLit) EWHC: Trial judge says ‘Boileau’ to patent licence; appeal court agrees: Oxonica Energy Ltd v Neuftec… [read post]
1 May 2009, 9:00 am
Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax (Naproxen)… [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending… [read post]
10 Oct 2008, 3:22 pm
In August 1995, Guidant witnessed its first internal defibrillator (the Ventak Mini I) implanted and only seven months later in March 1996; the Ventak Mini II (13% smaller than its predecessor and the smallest in the world) became the new standard, overtaking models that rivals, including Medtronic, were manufacturing. [read post]
25 Sep 2008, 10:06 am
Reflections on the Interpretation of Article 27 TRIPS from Novartis v. [read post]
